These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20921293)

  • 1. Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan.
    Hirahara I; Inoue M; Umino T; Saito O; Muto S; Kusano E
    Nephrol Dial Transplant; 2011 May; 26(5):1695-701. PubMed ID: 20921293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis.
    Igarashi Y; Morishita Y; Yoshizawa H; Imai R; Imai T; Hirahara I; Akimoto T; Ookawara S; Ishibashi K; Muto S; Nagata D
    Ren Fail; 2017 Nov; 39(1):392-399. PubMed ID: 28201944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What does the dialysate level of matrix metalloproteinase 2 tell us?
    Ertilav M; Timur O; Hür E; Bozkurt D; Nar H; Kologlu T; Sen S; Duman S
    Adv Perit Dial; 2011; 27():6-10. PubMed ID: 22073820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients.
    Sawai A; Ito Y; Mizuno M; Suzuki Y; Toda S; Ito I; Hattori R; Matsukawa Y; Gotoh M; Takei Y; Yuzawa Y; Matsuo S
    Nephrol Dial Transplant; 2011 Jul; 26(7):2322-32. PubMed ID: 21098014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.
    Oh KH; Moon JY; Oh J; Kim SG; Hwang YH; Kim S; Lee JS; Ahn C
    Nephrol Dial Transplant; 2008 Jul; 23(7):2356-64. PubMed ID: 18178604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.
    Hirahara I; Ogawa Y; Kusano E; Asano Y
    Nephrol Dial Transplant; 2004 Jul; 19(7):1732-41. PubMed ID: 15128883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction.
    Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
    Perit Dial Int; 2016; 36(1):16-25. PubMed ID: 25292407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extended assessment of peritoneal transport kinetics of substances and water as an important element of integrated dialysis care].
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):110-3. PubMed ID: 15603317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solutes transport characteristics in peritoneal dialysis: variations in glucose and insulin serum levels.
    da Silva DR; Figueiredo AE; Antonello IC; Poli de Figueiredo CE; d'Avila DO
    Ren Fail; 2008; 30(2):175-9. PubMed ID: 18300117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
    Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
    Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of encapsulating peritoneal sclerosis at the clinical early stage with high concentration of matrix metalloproteinase-2 in peritoneal effluent.
    Masunaga Y; Hirahara I; Shimano Y; Kurosu M; Iimura O; Miyata Y; Amemiya M; Homma S; Kusano E; Asano Y
    Clin Exp Nephrol; 2005 Mar; 9(1):85-9. PubMed ID: 15830280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
    Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.